Tech Company Financing Transactions
NeuraLace Funding Round
NeuraLace, based in San Diego, received $2 million in investment from FusionX Ventures and private investors.
Transaction Overview
Company Name
Announced On
3/17/2017
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors
FusionX Ventures (Lead Investor) (Ken Hood)
Proceeds Purpose
The investment will be used to secure FDA 510(k) approval and to launch NeuraLace Medical's Axon Therapy nerve pain alleviation treatment. Once approved, Axon Therapy devices will be manufactured by D&K Engineering in San Diego.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Undisclosed
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Not Recorded
Overview
At NeuraLace, we believe in interfacing the gap that exists between technology and human neurology to deliver effective pain relief and improve patients quality of life as a result of suffering from chronic pain.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Shiv Shukla
Chief Financial Officer
Thomas Broadhead
Browse more venture capital transactions:
Prev: 3/17/2017: eGenesis venture capital transaction
Next: 3/17/2017: Collective Retreats venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs